We're developing a better treatment for the up to 400 million men worldwide who suffer from urinary obstruction related to benign prostatic hyperplasia (BPH or enlarged prostate). We aim to give men a new option that relieves symptoms permanently without requiring a painful, invasive procedure and risking serious complications.